IONIS PHARMACEUTICALS INC Insider Trading for November 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IONIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IONIS PHARMACEUTICALS INC for November 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Development | Option Exercise | M | 39.87 | 11,920 | 475,250 | 0 | |
| Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Development | Sell | S | 50.05 | 11,920 | 596,596 | 30,447 | 42.4 K to 30.4 K (-28.14 %) |
| Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | EVP, Development | Buy | M | 39.87 | 11,920 | 475,250 | 42,367 | 30.4 K to 42.4 K (+39.15 %) |
| Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Option Exercise | M | 39.87 | 21,680 | 864,382 | 0 | |
| Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell | S | 50.05 | 21,680 | 1,085,084 | 32,495 | 54.2 K to 32.5 K (-40.02 %) |
| Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Buy | M | 39.87 | 21,680 | 864,382 | 54,175 | 32.5 K to 54.2 K (+66.72 %) |
| Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 39.87 | 12,990 | 517,911 | 0 | |
| Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.05 | 12,990 | 650,150 | 2,021 | 15 K to 2 K (-86.54 %) |
| Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 39.87 | 12,990 | 517,911 | 15,011 | 2 K to 15 K (+642.75 %) |
| Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | M | 39.87 | 3,590 | 143,133 | 0 | |
| Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Sell | S | 50.05 | 3,590 | 179,680 | 67,464 | 71.1 K to 67.5 K (-5.05 %) |
| Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Buy | M | 39.87 | 3,590 | 143,133 | 71,054 | 67.5 K to 71.1 K (+5.32 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 39.87 | 2,590 | 103,263 | 12,990 | |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 39.87 | 11,600 | 462,492 | 15,580 | |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 39.87 | 500 | 19,935 | 0 | |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.83 | 2,590 | 131,650 | 2,021 | 4.6 K to 2 K (-56.17 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 39.87 | 2,590 | 103,263 | 4,611 | 2 K to 4.6 K (+128.15 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.11 | 11,600 | 581,276 | 2,021 | 13.6 K to 2 K (-85.16 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 39.87 | 11,600 | 462,492 | 13,621 | 2 K to 13.6 K (+573.97 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.00 | 500 | 25,000 | 1,581 | 2.1 K to 1.6 K (-24.03 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 39.87 | 500 | 19,935 | 2,081 | 1.6 K to 2.1 K (+31.63 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Option Exercise | M | 39.87 | 4,320 | 172,238 | 21,680 | |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Option Exercise | M | 39.87 | 5,875 | 234,236 | 26,000 | |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Option Exercise | M | 39.87 | 13,125 | 523,294 | 31,875 | |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell | S | 50.83 | 4,320 | 219,586 | 32,495 | 36.8 K to 32.5 K (-11.73 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Buy | M | 39.87 | 4,320 | 172,238 | 36,815 | 32.5 K to 36.8 K (+13.29 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell | S | 50.11 | 5,875 | 294,396 | 32,495 | 38.4 K to 32.5 K (-15.31 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Buy | M | 39.87 | 5,875 | 234,236 | 38,370 | 32.5 K to 38.4 K (+18.08 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell | S | 50.11 | 13,125 | 657,694 | 32,495 | 45.6 K to 32.5 K (-28.77 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | EVP, Finance & CFO | Buy | M | 39.87 | 13,125 | 523,294 | 45,620 | 32.5 K to 45.6 K (+40.39 %) |
| Nov 05 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Option Exercise | M | 39.87 | 15,000 | 598,050 | 15,000 | |
| Nov 05 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Sell | S | 46.77 | 15,000 | 701,600 | 32,476 | 47.5 K to 32.5 K (-31.59 %) |
| Nov 05 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Buy | M | 39.87 | 15,000 | 598,050 | 47,476 | 32.5 K to 47.5 K (+46.19 %) |
| Nov 05 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Option Exercise | M | 39.87 | 15,000 | 598,050 | 15,000 | |
| Nov 05 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Sell | S | 46.77 | 15,000 | 701,600 | 32,476 | 47.5 K to 32.5 K (-31.59 %) |
| Nov 05 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Buy | M | 39.87 | 15,000 | 598,050 | 47,476 | 32.5 K to 47.5 K (+46.19 %) |